Global Products Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Products Reporter.

Press releases published on September 3, 2026

Proofpoint Brings OpenAI GPT Cyber Models into Security Operations to Help Defenders Investigate Threats Faster
Sophos To Bring OpenAI GPT Cyber Models Into Managed Risk Offering, Helping Defenders Validate Exploit Paths
Securities Fraud Investigation Into Better Home & Finance Holding Company (BETR) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Benchmade Knife Company Announces Three-Year Partnership with Oregon Sports Properties, Home of the Oregon Ducks
Shirofune Integrates with Campaign Manager 360
Bragar Eagel & Squire, P.C. Reminds Megan Holdings Limited (MGN) Investors to Contact the Firm Regarding the Lead Plaintiff Role Before September 8th
As AI reshapes business, Newsmatics teams up with Masaryk University to let students tackle real-world challenges
Collaborative for Children to Rally Houston Leaders Around Early Education at 2026 Building Blocks Luncheon
Securities Fraud Investigation Into Upwork Inc. (UPWK) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Rogers and Quebecor Agree to New 12-Year Sublicensing Deal for National NHL Games in French
Rogers et Québecor concluent une nouvelle entente de sous-licence de 12 ans visant les droits nationaux de diffusion des matchs de la LNH en français
QCI Surpasses 100 Patent Assets in Casino Technology Innovation
Intuit Inc. Investors Have Until September 8th to Seek Lead Plaintiff Role with Bragar Eagel & Squire, P.C.
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System
DUFT&DOFT Takes 600-Store Olive Young Record Global with Fragrance-Led Personal Care
PicPay Announces Integration with Claude, Expanding Customer Access to Financial Information through Generative AI
Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism
L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.
Mama’s Creations Reports Second Quarter Fiscal 2027 Financial Results
XPO Provides North American LTL Operating Data for August 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Products Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.